Weekly signal · ILMN · Healthcare

Illumina Inc (ILMN) finishes latest week with a 42.9% 12-week climb

The diagnostics and research stock remains in an active weekly trend, but lighter volume and modest Relative Strength keep the setup mixed.

Illumina Inc
Latest194.09 USD
1W move4.0%
Volume0.8x
TrendActive
Weekly market chart context for Illumina alongside DNA sequencing and diagnostics equipment.

Market update

What happened

Illumina Inc (ILMN) closed the latest week at 194.09 USD, adding 4.0% on the week in weekly context over a 52-week price path.

The move is backed by a 9.9% four-week gain and Market Dynamics confirmation at 1.32. The evidence is not one-way: weekly volume of 6.94 million shares trailed the 13-week average of 8.90 million, while Relative Strength stood at 38.0.

Continue your research

Explore ILMN across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

ILMN coverage

Evidence context